Lead sponsor
Huashan Hospital
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
0
Active
90
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
1
Trials by status
Unknown
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Comparison of Body Weight Change Through Different Smeglutide Administration MethodsBMI ≥24Ph 4Unknown80
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage—not applicableUnknown10